JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David W. Quinn
Domenico Pagano
Robert S. Bonser
Stephen J. Rooney
Timothy R. Graham
Ian C. Wilson
Bruce E. Keogh
Michael E. Lewis
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinn, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, D. W.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Cerebral protection
Right arrow Coronary disease
Right arrow Myocardial protection
Right arrowRelated Article

J Thorac Cardiovasc Surg 2006;131:34-42
© 2006 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology

Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: A randomized controlled trial

David W. Quinn, BSc, FRCS, Domenico Pagano, MD, FRCS, FESC, Robert S. Bonser, FRCP, FRCS, FESC * , * , Stephen J. Rooney, MB, FRCS, Timothy R. Graham, MB, FRCS, Ian C. Wilson, MD, FRCS, Bruce E. Keogh, MD, FRCS, John N. Townend, MD, FRCP, Michael E. Lewis, MD, FRCS, Peter Nightingale, PhD Study Investigators {ddagger}

Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Edgbaston, Birmingham, United Kingdom.

Received for publication March 14, 2005; revisions received May 11, 2005; accepted for publication May 26, 2005.

* Address for reprints: Robert S. Bonser, FRCP, FRCS, Consultant Cardiothoracic Surgeon, Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, University Hospital Birmingham NHS trust, Edgbaston, Birmingham, UK, B15 2TH. (Email: robert.bonser{at}uhb.nhs.uk).

OBJECTIVE: We sought to assess the role of glucose-insulin-potassium in providing myocardial protection in nondiabetic patients undergoing coronary artery surgery with cardiopulmonary bypass.

METHODS: A prospective, randomized, double-blind, placebo-controlled trial was conducted at a single-center university hospital performing adult cardiac surgery. Two hundred eighty nondiabetic adult patients undergoing first-time elective or urgent isolated multivessel coronary artery bypass grafting were prospectively randomized to receive glucose-insulin-potassium infusion or placebo (dextrose 5%) before, during, and for 6 hours after surgical intervention. Anesthetic, cardiopulmonary bypass, myocardial protection, and surgical techniques were standardized. The primary end point was postreperfusion cardiac index. Secondary end points were systemic vascular resistance index, the incidence of low cardiac output episodes, inotrope and vasoconstrictor use, and biochemical-electrocardiographic evidence of myocardial injury. The incidence of dysrhythmias and infections requiring treatment was recorded prospectively.

RESULTS: The glucose-insulin-potassium group experienced higher cardiac indices (P < .001) throughout infusion and reduced vascular resistance (P < .001). The incidence of low cardiac output episodes was 15.9% (22/138) in the glucose-insulin-potassium group and 27.5% (39/142) in the placebo group (P = .021). Inotropes were required in 18.8% (26/138) of the glucose-insulin-potassium group and 40.8% (58/142) of the placebo group (P < .001). Fewer patients in the glucose-insulin-potassium group (12.3% [16/133]) versus those in the placebo group (23.4% [32/137]) had significant myocardial injury (P = .017). Noncardiac morbidity was not different.

CONCLUSION: Glucose-insulin-potassium therapy improves early postoperative cardiovascular performance, reduces inotrope requirement, and might reduce myocardial injury. These potential benefits are not at the expense of increased noncardiac morbidity.



Abbreviations and acronyms AF = atrial fibrillation; ANOVA = analysis of variance; CABG = coronary artery bypass grafting; CI = cardiac index; CPB = cardiopulmonary bypass; cTnI = cardiac troponin I; ECG = electrocardiogram; GIK = glucose-insulin-potassium; IQR = interquartile range; ITU = intensive therapy unit; LCOE = episodes of low cardiac output; NYHA = New York Heart Association; PMI = perioperative myocardial infarction; SD = standard deviation; SVR = systemic vascular resistance; SVRI = systemic vascular resistance index; WBG = whole blood glucose



Related Article

Hyperglycemia during cardiac surgery
Harold L. Lazar
J. Thorac. Cardiovasc. Surg. 2006 131: 11-13. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Clin PharmacolHome page
M. A. Puskarich, M. S. Runyon, S. Trzeciak, J. A. Kline, and A. E. Jones
Effect of Glucose-Insulin-Potassium Infusion on Mortality in Critical Care Settings: A Systematic Review and Meta-Analysis
J. Clin. Pharmacol., July 1, 2009; 49(7): 758 - 767.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Z. Yang, V. E. Laubach, B. A. French, and I. L. Kron
Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 723 - 729.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Ceriello, S. W. Zarich, and R. Testa
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.
J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S9 - 13.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty
Insulin as an anti-inflammatory and antiatherogenic modulator.
J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S14 - S20.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. J. Zuurbier, F. J. Hoek, J. van Dijk, N. G. Abeling, J. C. M. Meijers, J. H. M. Levels, E. de Jonge, B. A. de Mol, and H. B. Van Wezel
Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery
Br. J. Anaesth., April 1, 2008; 100(4): 442 - 450.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
G. Y. Gandhi, M. H. Murad, D. N. Flynn, P. J. Erwin, A. B. Cavalcante, H. B. Nielsen, S. E. Capes, K. Thorlund, V. M. Montori, and P. J. Devereaux
Effect of Perioperative Insulin Infusion on Surgical Morbidity and Mortality: Systematic Review and Meta-analysis of Randomized Trials
Mayo Clin. Proc., April 1, 2008; 83(4): 418 - 430.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A. Ballweg, G. Wernovsky, R. F. Ittenbach, J. Bernbaum, M. Gerdes, P. R. Gallagher, T. E. Dominguez, E. Zackai, R. R. Clancy, S. C. Nicolson, et al.
Hyperglycemia After Infant Cardiac Surgery Does Not Adversely Impact Neurodevelopmental Outcome
Ann. Thorac. Surg., December 1, 2007; 84(6): 2052 - 2058.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Ranasinghe, C. J. McCabe, D. W. Quinn, S. R. James, D. Pagano, J. A. Franklyn, and R. S. Bonser
How Does Glucose Insulin Potassium Improve Hemodynamic Performance?: Evidence for Altered Expression of Beta-Adrenoreceptor and Calcium Handling Genes
Circulation, July 4, 2006; 114(1_suppl): I-239 - I-244.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, January 28, 2006; 332(7535): 246 - 246.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. L. Lazar
Hyperglycemia during cardiac surgery
J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 11 - 13.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.